Hereditary Malignant Neoplasm — Trials

Hereditary Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

78 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 25
Recruiting: 14
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06488378	Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer	recruiting	Phase 1	20	Dana-Farber Cancer InstituteOTHER	1	Sep 2, 2026	clinicaltrials
NCT04726241	The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study	recruiting	Phase 1 / Phase 2	960	PedAL BCU, LLCOTHER	5